secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0001493152-24-023525
Event type: debt
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma enters loans totaling $120K AUD at 12% interest
-----------------------------------------------------------------

- First loan of $20,000 AUD on June 3, 2024, at 12% annual interest, maturing June 3, 2025.
- Second loan of $100,000 AUD on June 5, 2024, at 12% annual interest, maturing June 5, 2025.
- Proceeds used for general working capital; prepayment allowed without penalty.
- Loans issued under Section 4(a)(2) private placement exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224023525/0001493152-24-023525-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224023525/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-023525

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer